Shenzhen - Delayed Quote CNY

Luyan Pharma Co.,Ltd. (002788.SZ)

8.12

+0.04

+(0.50%)

At close: 3:04:15 PM GMT+8

Novo Nordisk beats on Q1 earnings, cuts 2025 outlook

Novo Nordisk reported moderate earnings, cuts 2025 outlook

Yahoo Finance 10 seconds ago

HIMS

LLY

CVS
Nvidia CEO Jensen Huang says dropping chip restrictions would bring jobs to the US

Nvidia CEO Jensen Huang makes a case for no chip restrictions.

Yahoo Finance 12 hours ago

AMD

NVDA
Upstart is in 'growth mode': CEO talks Q1 sales beat, Q2 outlook

Upstart (UPST) reported its first quarter earnings Tuesday after the closing bell. Revenue came in at $213.4 million, beating estimates of $203.4 million. However, the company's second quarter revenue forecast came in at $225 million, falling short of expectations of $227.8 million. Market Domination Overtime host Josh Lipton sits down with Upstart CEO Dave Girouard to discuss the company's earnings print. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 14 hours ago

UPST
Rivian warns of tariff impact

Rivian (RIVN) posted first quarter revenue of $1.24 billion, which topped the Bloomberg consensus estimate of $981.2 million. The EV-maker also reported a smaller loss than expected. However, the company did raise its capital expenditure forecast to $1.80 billion to $1.90 billion. Yahoo Finance Senior Autos Reporter Pras Subramanian reports the numbers.  To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 14 hours ago

RIVN
Hims surges, SolarEdge earnings beat, Rivian expands in Illinois

Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Hims & Hers Health (HIMS) seeing a bump higher in its stock price despite disappointing on guidance, SolarEdge Technologies' (SEDG) first quarter earnings beat, and electric vehicle maker Rivian (RIVN) planning to build out a supplier park in Normal, Illinois. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 18 hours ago

SEDG

HIMS

RIVN
AMD earnings preview, Datadog, Ferrari profits: Trending Tickers

Catalysts host Madison Mills and Strategas Research Partners head of technical & macro research Chris Verrone examine some of Tuesday morning's trending tickers. Advanced Micro Devices (AMD) is in focus ahead of the company's first quarter earnings results, which will be released after the closing bell on Tuesday. The chipmaker's results and guidance could offer insight into the greater artificial intelligence (AI) landscape. Datadog (DDOG) topped first quarter earnings estimates and lifted its second quarter guidance. Ferrari (RACE) reported a 15% year-over-year profit increase in its first quarter, though the company emphasized that tariffs could impact its profitability going forward. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 19 hours ago

DDOG

AMD

RACE
AMD Issues Upbeat Revenue Outlook Despite Export Restrictions; Quarterly Results Top Views

Advanced Micro Devices (AMD) shares rose early Wednesday as it issued an upbeat fiscal second-quarte

PREMIUM
MT Newswires 24 minutes ago

AMD
Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance

NEW YORK, May 07, 2025--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March 31, 2025.

Business Wire 53 minutes ago

OSCR
Novo Nordisk's CFO sceptical Trump executive order on drug manufacturing can cut timelines

LONDON/COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to reduce the time it takes to approve pharmaceutical plants in the country will significantly change timelines for the pharma industry. Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharma plants in the United States, as part of new regulations to encourage domestic manufacturing. Novo Nordisk Chief Financial Officer Karsten Munk Knudsen said in an interview it takes years for a pharmaceutical company to build a factory in compliance with the quality protocols set and enforced by the U.S. Food and Drug Administration (FDA).

Reuters 1 hour ago

NVO
These Stocks Are Moving the Most Today: Super Micro, AMD, Novo Nordisk, Sarepta, EA, Rivian, Tesla, and More

Super Micro Computer’s guidance for its fiscal fourth quarter misses analysts’ estimates, while Advanced Micro Devices top earnings forecasts as data-center revenue jumps 57%.

Barrons.com 1 hour ago

SMCI

RIVN

AMD
Novo Nordisk Cuts Guidance as Weight-Loss Drug Sales Slow. Why the Stock Is Jumping.

The Danish drugmaker now expects sales growth between 13% and 21%, down from a previous range of 16% to 24%.

Barrons.com 1 hour ago

NVO

LLY
Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.

No matter how high President Trump cranks up tariffs, many industries are never coming back to the U.S. For industries that require cheap labor such as apparel and toys, bringing that production to Pennsylvania or Ohio just doesn’t make sense. For pharma, an industry in which gross margins are among the highest in the S&P 500, labor was never really the reason for moving offshore to places like Ireland—it was always about playing the global tax game. Tariffs are certainly getting pharma CEOs to listen, and many are already stockpiling imports while expanding production within existing U.S. sites.

The Wall Street Journal 1 hour ago

JNJ

PFE

LLY
Geely Proposes to Take Zeekr Private

Chinese automaker Geely Automobile said it plans to privatize its Zeekr brand, just shy of a year after its U.S. initial public offering. The Hangzhou-based automaker said Wednesday that it proposed to privatize Zeekr by acquiring all of its issued and outstanding shares and its American depositary shares. The move will help “drive deep integration and efficient collaboration of internal resources, eliminate redundant investments, reduce costs, enhance corporate competitiveness and create long-term value,” Geely said in a statement.

The Wall Street Journal 1 hour ago

GELYF

GELYY

ZK
Novo Nordisk latest drugmaker to drop gender goals in US

Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for its U.S. business following executive orders by President Donald Trump to stop diversity, equity and inclusion initiatives. "While Novo Nordisk maintains our global aspiration of a minimum 45% representation for each gender by the end of 2025, Novo Nordisk's operations in the U.S. will no longer participate in this global initiative due to evolving legal requirements," the company said in its first-quarter earnings statement. Following Trump taking office in January and up to Wednesday, the Danish company had, when asked, affirmed it would not change its stance on the importance of a diverse workforce.

Reuters 1 hour ago

NVO
Nvidia Stock Gains. Why It Got an AMD and Super Micro Earnings Boost.

Nvidia was reacting after rival Advanced Micro Devices and partner Super Micro Computer reported earnings.

Barrons.com 1 hour ago

AMD

SMCI

NVDA
Trending tickers: AMD, Novo Nordisk, Rivian, Super Micro and Trainline

The latest investor updates on stocks that are trending on Wednesday.

Yahoo Finance UK 1 hour ago

^IXIC

RIVN

TNLIF
Novo Nordisk: Q1 Earnings Snapshot

BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported first-quarter earnings of $4.09 billion. The Bagsvaerd, Denmark-based company said it had profit of 92 cents per share. The results matched Wall Street expectations.

Associated Press Finance 1 hour ago

NVO
Chinese carmaker Geely offers to take Zeekr unit private in $2.2 billion deal

Geely offered to pay $25.66 per Zeekr's American Depositary Share, a premium of 13.6% to the stock's closing price on Tuesday. As of May 7, Geely held around 65.7% of the total issued and outstanding share capital of Zeekr. Zeekr's ADSs jumped 11.11% to $25.10 in U.S. premarket trading.

Reuters 1 hour ago

ZK

GELYY
Bitcoin Price Rises as the U.S. and China Set to Start Trade Talks

Treasury Secretary Scott Bessent will meet Chinese officials this week in Switzerland to discuss trade matters.

Barrons.com 2 hours ago

ETH-USD

BTC-USD

XRP-USD
Why Oklo Inc. (OKLO) Skyrocketed On Tuesday

We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at where Oklo Inc. (NYSE:OKLO) stands against other Tuesday’s best-performing stocks. The stock market ended the trading session in the red on Tuesday, with all major indices giving up earlier gains, as […]

Insider Monkey 3 hours ago

OKLO

^GSPC

Performance Overview

Return	002788.SZ	SSE Composite Index (000001.SS)
YTD	-1.10%	-0.27%
1-Year	-6.68%	+6.19%
3-Year	+15.41%	+11.36%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Luyan Pharma Co.,Ltd. (002788.SZ)

Related News

Novo Nordisk beats on Q1 earnings, cuts 2025 outlook

Nvidia CEO Jensen Huang says dropping chip restrictions would bring jobs to the US

Upstart is in 'growth mode': CEO talks Q1 sales beat, Q2 outlook

Rivian warns of tariff impact

Hims surges, SolarEdge earnings beat, Rivian expands in Illinois

AMD earnings preview, Datadog, Ferrari profits: Trending Tickers

AMD Issues Upbeat Revenue Outlook Despite Export Restrictions; Quarterly Results Top Views

Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance

Novo Nordisk's CFO sceptical Trump executive order on drug manufacturing can cut timelines

These Stocks Are Moving the Most Today: Super Micro, AMD, Novo Nordisk, Sarepta, EA, Rivian, Tesla, and More

Novo Nordisk Cuts Guidance as Weight-Loss Drug Sales Slow. Why the Stock Is Jumping.

Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.

Geely Proposes to Take Zeekr Private

Novo Nordisk latest drugmaker to drop gender goals in US

Nvidia Stock Gains. Why It Got an AMD and Super Micro Earnings Boost.

Trending tickers: AMD, Novo Nordisk, Rivian, Super Micro and Trainline

Novo Nordisk: Q1 Earnings Snapshot

Chinese carmaker Geely offers to take Zeekr unit private in $2.2 billion deal

Bitcoin Price Rises as the U.S. and China Set to Start Trade Talks

Why Oklo Inc. (OKLO) Skyrocketed On Tuesday

Performance Overview